Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Gordon

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Experimental Biology|March 29, 2001
Boxfishes (Teleostei: Ostraciidae) as a model system for fishes swimming with many fins: kinematicsJ R Hove, L M O'Bryan, M S Gordon, et al.
American Journal of Clinical Pathology|February 1, 1995
In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsiesA Orazi, M S Gordon, K John, et al.
The Journal of Biological Chemistry|May 17, 2001
The ATPase reaction cycle of yeast DNA topoisomerase II. Slow rates of ATP resynthesis and P(i) releaseC L Baird, M S Gordon, D M Andrenyak, et al.
American Journal of Hypertension|June 1, 1990
Dopamine and nonmodulating hypertensionG H Williams, M S Gordon, C A Stuenkel, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1989
The role of dopamine in nonmodulating hypertensionM S Gordon, C A Steunkel, P R Conlin, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymomaM S Gordon, L A Battiato, R Gonin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2000
Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cellsM S Gordon, R M Kato, F Lansigan, et al.
Blood Cells, Molecules & Diseases|June 6, 1998
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancerH E Broxmeyer, A Orazi, N L Hague, et al.
Transactions of the Association of American Physicians|January 1, 1993
The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cellsJ Tong, M S Gordon, E F Srour, et al.
Blood|August 1, 1993
In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cellsJ Tong, M S Gordon, E F Srour, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Experimental Biology|March 29, 2001
Boxfishes (Teleostei: Ostraciidae) as a model system for fishes swimming with many fins: kinematicsJ R Hove, L M O'Bryan, M S Gordon, et al.
American Journal of Clinical Pathology|February 1, 1995
In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsiesA Orazi, M S Gordon, K John, et al.
The Journal of Biological Chemistry|May 17, 2001
The ATPase reaction cycle of yeast DNA topoisomerase II. Slow rates of ATP resynthesis and P(i) releaseC L Baird, M S Gordon, D M Andrenyak, et al.
American Journal of Hypertension|June 1, 1990
Dopamine and nonmodulating hypertensionG H Williams, M S Gordon, C A Stuenkel, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1989
The role of dopamine in nonmodulating hypertensionM S Gordon, C A Steunkel, P R Conlin, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymomaM S Gordon, L A Battiato, R Gonin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2000
Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cellsM S Gordon, R M Kato, F Lansigan, et al.
Blood Cells, Molecules & Diseases|June 6, 1998
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancerH E Broxmeyer, A Orazi, N L Hague, et al.
Transactions of the Association of American Physicians|January 1, 1993
The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cellsJ Tong, M S Gordon, E F Srour, et al.
Blood|August 1, 1993
In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cellsJ Tong, M S Gordon, E F Srour, et al.
Pageof 10